Introduction To Clinical Epidemiology
Introduction To Clinical Epidemiology
Introduction To Clinical Epidemiology
JULIANDI HARAHAP, MA
Dept. of Communitiy Medicine
FK USU
Sciencewhich is about the distribution of
disease (or consequence of disease) in
populations
Set
of methods used to reduce uncertainty
about information
The study of the distribution and determinants of
disease in human populations.
Study
Methods are intended to be scientific (basic science of public
health)
Epidemiology is reasoned argument
Distribution
Descriptive Epi – person, place, time
Look for patterns among different groups
Determinants
Epi Triad – Agent, Host, Environment
Causality – Criteria (AB Hill), Induction vs. Deduction (Popper)
Populations
Probability (chance) and Statistics
Study Designs
CE is the science of making predictions about
individual patiens by counting clinical events in
groups of similar patients and using strong
scientific methods to ensure that the predictions
are accurate.
Aims:
1. Provide clinicians with optimal strategies for
diagnosis, treatment and prognosis,
improvement of clinical decision making.
2. Better clinical decision results from studies
evidencing real facts, evidence based
medicine.
Clinical
Epidemiology
A basic science for clinical medicine
(Sackett et al, 1991)
1. Formulate question (hypothesis)
2. Choose study design
3. Choose study population base and sample
from that base
4. Collect and analyze data
5. Interpret results
Elements of a good question (hypothesis)
Target population
Target exposure (risk factor, protective factor,
treatment) and its control
Specified outcome
Example: In adults is hypertension associated with an
increased risk of coronary artery disease?
B. Observational
1) Cohort (incidence) study
2) Case-control study
3) Cross-sectional (survey, prevalence) study
Also called randomized, controlled trial (RCT)
Randomly assign “exposure” (usually an
intervention) to study population
Measure “outcome” during some follow-up period
Best method to eliminate selection bias (required
for pharmacologic treatment by FDA)
However
– Some exposures cannot be randomly allocated
– Selection criteria may limit generalizability
– High cost
Classify individuals in study population into
“exposure” categories
Measure “outcome” during some follow-up period
Can be retrospective or prospective
Feasible for common outcomes, less costly than
RCTs
However
– Subject to selection bias
– Among observational study designs most costly
– Not feasible for rare outcomes
Choose a sample of individuals with the
“outcome” of interest (cases) and a sample of
individuals without the “outcome” (controls)
Assess “exposure” status of study population
sometimes in the past
Retrospective except for nested case-control
studies, i.e. when case and control subjects are
drawn from a cohort study
Advantages: less costly, appropriate for rare
outcomes
Disadvantages: more subject to bias
Also called a prevalence study
Assess “exposure” and “outcome” of study
population at the same time
Advantage: least expensive of observational
studies
Disadvantage: no temporal relationship between
“exposure” and “outcome”
Struggle between access and generalizability
Population Base choices include
– Active patients (clinic/hospital)
– Community residents (geographic)
– Combination
Sampling choices include
– Random sampling
– Stratified random sampling
– Convenience sampling
Depends on study design
Sensitivity and specificity in studies of
diagnostic tests
Relative risk and odds ratios in studies of
association between risk factors and
outcomes
Threats to the validity of epidemiologic
studies
- Chance
Internal validity
The degree to which the results of a study
are correct for the sample of patients being
studied
External validity
The degree to which the results of an
observation hold true in other settings
Selection bias
Occurs when selection and/or follow-up procedures
lead to study group differences in determinants of
outcome other than the one under study
Measurement bias
Occurs when measurements are imprecise and/or the
methods of measurement are dissimilar among study
groups
Confounding bias
Occurs when two factors are associated (“travel
together”) and the effect of one is confused with or
distorted by the effect of another)
Due to selection or by chance
Restriction (exclude the young)
Matching (for every 50 year old with BP+,
find a 50 year old with BP-
Stratification at enrollment (set sample size
for each decade of age)
Statistical adjustment (stratification of data,
standardization, multivariate adjustment)
Use “objective” and precise measures when
possible
Blinding of assessors of outcome to risk
status of subject and vice versa
Assess extent of measurement (information)
bias by comparing responses to external
information (e.g. pharmacy records, or
health utilization data bases)
Arises from sampling and measurement
Assessed by statistical methods